39126 Federal Register / Vol. 87, No. 125 / Thursday, June 30, 2022 / Notices 

review, we cannot guarantee that we 

will be able to do so. 

Abstract: The principal purpose for 

collecting the requested information is 

to recruit eligible students to participate 

in Reclamation’s Technical Service 

Center Summer Intern Program. General 

contact information will be collected 

along with information on academic 

standing and areas/fields of interest. 

Respondents are also asked to submit an 

interest letter and resume. 

Title of Collection: Technical Service 

Center Summer Intern Program 

Application. 

OMB Control Number: 1006–NEW. 

Form Number: 7–3000. 

Type of Review: New, in use without 

OMB approval. 

Respondents/Affected Public: 

Students interested in internships at 

Reclamation. 

Total Estimated Number of Annual 

Respondents: 150. 

Total Estimated Number of Annual 

Responses: 150. 

Estimated Completion Time per 

Response: 140 minutes. 

Total Estimated Number of Annual 

Burden Hours: 350 hours. 

Respondent’s Obligation: Required to 

obtain or retain a benefit. 

Frequency of Collection: Annually. 

Total Estimated Annual Non-hour 

Burden Cost: $0. 

An agency may not conduct or 

sponsor and a person is not required to 

respond to a collection of information 

unless it displays a currently valid OMB 

control number. 

The authority for this action is the 

Paperwork Reduction Act of 1995 (44 

U.S.C. 3501 et seq). 

Richard LaFond, 

Director, Technical Service Center. 

[FR Doc. 2022–14047 Filed 6–29–22; 8:45 am] 

BILLING CODE 4332–90–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1032] 

Importer of Controlled Substances 

Application: Cambrex Charles City 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Cambrex Charles City has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before August 1, 2022. Such 

persons may also file a written request 

for a hearing on the application on or 

before August 1, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on May 9, 2022, Cambrex 

Charles City, 1205 11th Street, Charles 

City, Iowa 50616–3466, applied to be 

registered as an importer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Psilocybin ...................... 7437 I 

ANPP (4-Anilino-Nphenethyl-4-piperidine).8333 II 

Phenylacetone ............... 8501 II 

Coca Leaves ................. 9040 II 

Opium, raw .................... 9600 II 

Poppy Straw Concentrate.9670 II 

The company plans to import the 

listed controlled substances for internal 

use and to bulk manufacture other 

controlled substances into active 

pharmaceutical ingredient (API) form 

for distribution to its customers. No 

other activity for these drug codes is 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Kristi O’Malley, 

Assistant Administrator. 

[FR Doc. 2022–14041 Filed 6–29–22; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1027] 

Importer of Controlled Substances 

Application: Adiramedica, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Adiramedica, LLC. has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to Supplemental 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before August 1, 2022. Such 

persons may also file a written request 

for a hearing on the application on or 

before August 1, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 125 / Thursday, June 30, 2022 / Notices 39127 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on May 10, 2022, 

Adiramedica, LLC., 585 Turner 

Industrial Way, Aston Pennsylvania 

19014, applied to be registered as an 

importer of the following basic class(es) 

of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Tapentadol ...................... 9780 II 

The company plans to import 

Tapentadol in finished dosage form for 

clinical trials. No other activity for this 

drug code is authorized for this 

registration drug code is authorized for 

this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Kristi O’Malley, 

Assistant Administrator. 

[FR Doc. 2022–14036 Filed 6–29–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1031] 

Bulk Manufacturer of Controlled 

Substances Application: American 

Radiolabeled Chem 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: American Radiolabeled Chem 

has applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

Supplementary Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before August 29, 2022. Such 

persons may also file a written request 

for a hearing on the application on or 

before August 29, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on May 24, 2022, 

American Radiolabeled Chem, 101 Arc 

Drive, Saint Louis, Missouri 63146– 

3502, applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Gamma Hydroxybutyric Acid 2010 I 

Ibogaine ................................. 7260 I 

Lysergic acid diethylamide .... 7315 I 

Tetrahydrocannabinols .......... 7370 I 

Dimethyltryptamine ................ 7435 I 

1-[1-(2- 

Thienyl)cyclohexyl]piperidine.

7470 I 

Noroxymorphone ................... 9145 I 

Heroin .................................... 9200 I 

Normorphine .......................... 9313 I 

Amphetamine ......................... 1100 II 

Methamphetamine ................. 1105 II 

Amobarbital ............................ 2125 II 

Phencyclidine ......................... 7471 II 

Phenylacetone ....................... 8501 II 

Cocaine .................................. 9041 II 

Codeine .................................. 9050 II 

Dihydrocodeine ...................... 9120 II 

Oxycodone ............................. 9143 II 

Hydromorphone ..................... 9150 II 

Ecgonine ................................ 9180 II 

Hydrocodone .......................... 9193 II 

Meperidine ............................. 9230 II 

Metazocine ............................. 9240 II 

Methadone ............................. 9250 II 

Dextropropoxyphene, bulk 

(non-dosage forms).

9273 II 

Morphine ................................ 9300 II 

Oripavine ................................ 9330 II 

Thebaine ................................ 9333 II 

Oxymorphone ........................ 9652 II 

Phenazocine .......................... 9715 II 

Carfentanil .............................. 9743 II 

Fentanyl ................................. 9801 II 

The company plans to bulk 

manufacture the listed controlled 

substances for the internal use 

intermediates or for sale to its 

customers. The company plans to 

manufacture small quantities of the 

above-listed controlled substances as 

radiolabeled compounds for 

biochemical research. No other 

activities for these drug codes are 

authorized for this registration. 

Kristi O’Malley, 

Assistant Administrator. 

[FR Doc. 2022–14040 Filed 6–29–22; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1030] 

Importer of Controlled Substances 

Application: Aurobindo Pharma USA, 

Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Aurobindo Pharma USA, Inc. 

has applied to be registered as an 

importer of basic class(es) of controlled 

substance(s). Refer to Supplementary 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before August 1, 2022. Such 

persons may also file a written request 

for a hearing on the application on or 

before August 1, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 


jspears on DSK121TN23PROD with NOTICES1